Pharma & Biotech

While Eli Lilly's largest shareholder has been systematically divesting hundreds of millions in company stock, the pharmaceutical giant's share price...

The biopharmaceutical sector is witnessing significant momentum from Assembly Biosciences following the release of exceptional clinical trial data for its...

Celularity Inc. shares continued their downward trajectory on Friday, declining 3.76 percent to close at $2.05. During the trading session,...

German biotechnology firm BioNTech faces mounting investor anxiety as its stock experiences a significant downturn. Despite reporting extraordinary revenue growth,...

The biotechnology sector is currently experiencing unprecedented merger and acquisition activity, with Viking Therapeutics emerging as a potential target in...

Dare Bioscience shares experienced significant price swings following the biotechnology firm's announcement of a $4 million non-dilutive grant for its...

ZimVie Inc. is poised to conclude its tenure as a publicly traded entity after shareholders formally approved its acquisition by...

Akari Therapeutics experienced significant price volatility following the company's latest move to strengthen its intellectual property portfolio. The biopharmaceutical firm...

NRX Pharmaceuticals experienced a dramatic sell-off on Friday, with its stock price collapsing by nearly 11% to close at $3.17....

While Ocuphire Pharma's stock celebrates a spectacular rally, reaching new annual peaks with a stunning 50% surge over the past...